Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary bladder cancer. Selecting initial therapy.

G H Friedell

    Cancer
    |August 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Optimal bladder cancer therapy relies on a multidisciplinary approach. Accurate tumor assessment through cystoscopy and pathology is crucial for effective treatment planning and patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Breast cancer action plan for Kentucky.

    The Journal of the Kentucky Medical Association·2001
    Same author

    Community cancer control in a rural, underserved population: the Appalachian Leadership Initiative on Cancer Project.

    Journal of health care for the poor and underserved·2001
    Same author

    Cancer surveillance. A problem for Native Americans and Appalachian populations.

    Cancer·2001
    Same author

    Cervical cancer in Kentucky.

    The Journal of the Kentucky Medical Association·2000
    Same author

    Cancer registration in the United States.

    Japanese journal of clinical oncology·2000
    Same author

    Improving comprehension for cancer patients with low literacy skills: strategies for clinicians.

    CA: a cancer journal for clinicians·1998
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • Uro-oncology
    • Diagnostic Pathology

    Background:

    • Selecting optimal primary therapy for bladder cancer necessitates a comprehensive evaluation.
    • Current diagnostic methods primarily involve cystoscopic observation and morphologic assessment of tissue specimens.

    Purpose of the Study:

    • To outline the essential components of a multidisciplinary approach for bladder cancer therapy selection.
    • To emphasize the roles of urologists and pathologists in gathering critical diagnostic information.

    Main Methods:

    • Urologists create detailed cystoscopic diagrams noting tumor number, location, and appearance.
    • Cytopathologists precisely define abnormalities in cellular preparations.
    • Histopathologists provide microscopic diagnoses and assess muscle presence in biopsy specimens.

    Related Experiment Videos

    Main Results:

    • Accurate documentation of tumor characteristics (location, extent, virulence) is vital.
    • Host response evaluation is a key factor in treatment decisions.
    • Integration of information from urology and pathology ensures thorough patient assessment.

    Conclusions:

    • A multidisciplinary approach integrating cystoscopic and pathological data is fundamental for optimal bladder cancer treatment.
    • Continued development of laboratory approaches will further enhance diagnostic capabilities.